Bdenza 80mg Capsule

Bdenza 80mg Capsule contains Enzalutamide, is used to treat prostate cancer and may be other disorders. It works by blocking testosterone and other male hormones.

Uses of Bdenza 80mg Capsule:

• Metastatic castration-resistant prostate cancer.
• Non-metastatic castration-resistant prostate cancer.

How does a Bdenza 80mg Capsule work?

Enzalutamide is an androgen receptor blocker. It works by blocking the effects of androgens (male hormones such as testosterone) on prostate cancer cells, stopping them from growing and multiplying.

How to Use & Dosage:

It is normally taken by mouth once a day. Capsules should be swallowed whole, not chewed or opened. Capsules may be taken with or without food. It is important to take it at the same time each day and follow the directions on your prescription exactly.

Keep taking enzalutamide and any other medicines for prostate cancer you might be on, such as degarelix or leuprolide. More information is available from the manufacturer in patient information. Ask your doctor or chemist.

Possible Side Effects:

• Fatigue
• Nausea
• Vomiting
• Fever
• Hot flashes
• Hypertension
• Diarrhea
• Nausea
• Seizures

Safety Advise:

🫘 Kidney

Take Bdenza 80 mg capsule with caution in patients with renal disease. The dosage might need to be adjusted. Speak with your health care provider.

🫀 Liver

Bdenza Capsule should be used cautiously in patients with severe liver disease. The dosage might have to be altered. Please talk to your health care provider.

🤰 Pregnancy

Bdenza 80 mg capsule may harm the baby during pregnancy. Please talk to your healthcare provider.

🤱 Breast Feeding

There is no information regarding the use of Bdenza 80 mg capsule in nursing. Please consult your healthcare provider.

🍺 Alcohol

It is not known if it is safe to take Bdenza 80 mg capsule with alcohol. Consult your health care professional.

Storage Instructions:

Store at room temperature. Keep from moisture and heat.

References

1. Scher HI, Fizazi K, Saad F, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. New England Journal of Medicine. 2012;367(13):1187-1197.
2. Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. New England Journal of Medicine. 2018;378(26):2465-2474.
3. Brunton LL, Hilal-Dandan R, Knollmann BC, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw-Hill Education.
4. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. New Delhi: Jaypee Brothers Medical Publishers.
5. Astellas Pharma US Inc. Xtandi (enzalutamide) capsules: prescribing information. Northbrook, IL: Astellas Pharma US Inc.

Disclaimer:

IHS Enterprises’s primary objective is to guarantee the accuracy, reliability, and specialist review of the information it provides to customers. The contents and information provided on this website are for informational purposes only. They should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician for guidance and any questions you may have about any condition or medication. If you do read anything from IHS Enterprises, please do not discount or delay in seeking competent medical advice. We want to enhance the doctor-patient relationship, not substitute it.

Manufacturer details

Name: BDR Pharmaceuticals Internationals Pvt

Address: 407-408, Sharda Chambers, New Marine Lines, Mumbai 400 020 (Maharashtra), New Marine Lines, Marine Lines, Mumbai, Maharashtra 400020

Country of origin: India